FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289933213> ?p ?o ?g. }

• W4289933213 endingPage "100301" @default.
• W4289933213 startingPage "100301" @default.
• W4289933213 abstract "To describe the successful implementation of an enhanced public health surveillance system based on early detection, tracing contacts, and patient follow-up and support. A prospective observational cohort study conducted in Serrana, São Paulo State, Brazil. The implementation was based on four axes: increasing the access to SARS-CoV-2 testing; correct swab collection; testing patients with mild symptoms; and patient follow-up. Positivity rate, patient demographic and clinical characteristics, dynamics of disease severity, SARS-CoV-2 genome evolution, and the impact on COVID-19 research were assessed from August 23, 2020 to February 6, 2021 (between epidemiological week 35/2020 and 5/2021, a total of 24 weeks). The number of sites collecting rt-PCR for SARS-CoV-2 was increased from one to seven points and staff was trained in the correct use of personal protective equipment and in the swab collection technique. During the study period, 6728 samples were collected from 6155 participants vs. 2770 collections in a similar period before. SARS-CoV-2 RNA was detected in 1758 (26.1%) swabs vs. 1117 (36.7%) before the implementation of the surveillance system (p < 0.001). Positivity rates varied widely between epidemiological weeks 35/2020 and 5/2021 (IQR, 12.8%–31.3%). Out of COVID-19 patients, 91.1% were adults at a median age of 35 years (IQR, 25–50 years), 42.6% were men and 57.4% were women, with a SARS-CoV-2 positivity rate of 28.6% and 24.4% (p < 0.001), respectively. The most common symptoms were headache (72.6%), myalgia (65.0%), and cough (61.7%). Comorbidities were found in 20.8% of patients, the most common being hypertension and diabetes. According to the World Health Organization clinical progression scale, 93.5% of patients had mild disease, 1.6% were hospitalized with moderate disease, 3.2% were hospitalized with severe disease, and 1.4% died. The enhanced surveillance system led to the development of COVID-19 related research. The enhanced surveillance system in Serrana improved COVID-19 understanding and management. By integrating community and academic institutions, it was possible to monitor SARS-CoV-2 positive cases and variants, follow the epidemic trend, guide patients, and develop relevant research projects." @default.
• W4289933213 created "2022-08-06" @default.
• W4289933213 creator A5004518048 @default.
• W4289933213 creator A5005121949 @default.
• W4289933213 creator A5005154520 @default.
• W4289933213 creator A5019391041 @default.
• W4289933213 creator A5021838292 @default.
• W4289933213 creator A5038568957 @default.
• W4289933213 creator A5039194215 @default.
• W4289933213 creator A5050887248 @default.
• W4289933213 creator A5051853079 @default.
• W4289933213 creator A5060344910 @default.
• W4289933213 creator A5065713614 @default.
• W4289933213 creator A5078634959 @default.
• W4289933213 creator A5083390606 @default.
• W4289933213 creator A5089227790 @default.
• W4289933213 date "2022-12-01" @default.
• W4289933213 modified "2023-10-01" @default.
• W4289933213 title "The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil" @default.
• W4289933213 cites W2773863675 @default.
• W4289933213 cites W3012284084 @default.
• W4289933213 cites W3013153999 @default.
• W4289933213 cites W3015611009 @default.
• W4289933213 cites W3017190864 @default.
• W4289933213 cites W3019063854 @default.
• W4289933213 cites W3020349108 @default.
• W4289933213 cites W3031691549 @default.
• W4289933213 cites W3034858522 @default.
• W4289933213 cites W3038626525 @default.
• W4289933213 cites W3044195680 @default.
• W4289933213 cites W3044468596 @default.
• W4289933213 cites W3044852091 @default.
• W4289933213 cites W3049073980 @default.
• W4289933213 cites W3080450849 @default.
• W4289933213 cites W3088841725 @default.
• W4289933213 cites W3111279521 @default.
• W4289933213 cites W3117021508 @default.
• W4289933213 cites W3117997400 @default.
• W4289933213 cites W3134964205 @default.
• W4289933213 cites W3139292518 @default.
• W4289933213 cites W3146337558 @default.
• W4289933213 cites W3158922727 @default.
• W4289933213 cites W3159548556 @default.
• W4289933213 cites W3161318724 @default.
• W4289933213 cites W3163730577 @default.
• W4289933213 cites W3163852037 @default.
• W4289933213 cites W3185396494 @default.
• W4289933213 cites W3215565964 @default.
• W4289933213 cites W4200399215 @default.
• W4289933213 cites W4205805385 @default.
• W4289933213 cites W4220791072 @default.
• W4289933213 cites W4280488691 @default.
• W4289933213 doi "https://doi.org/10.1016/j.puhip.2022.100301" @default.
• W4289933213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35946045" @default.
• W4289933213 hasPublicationYear "2022" @default.
• W4289933213 type Work @default.
• W4289933213 citedByCount "2" @default.
• W4289933213 countsByYear W42899332132022 @default.
• W4289933213 countsByYear W42899332132023 @default.
• W4289933213 crossrefType "journal-article" @default.
• W4289933213 hasAuthorship W4289933213A5004518048 @default.
• W4289933213 hasAuthorship W4289933213A5005121949 @default.
• W4289933213 hasAuthorship W4289933213A5005154520 @default.
• W4289933213 hasAuthorship W4289933213A5019391041 @default.
• W4289933213 hasAuthorship W4289933213A5021838292 @default.
• W4289933213 hasAuthorship W4289933213A5038568957 @default.
• W4289933213 hasAuthorship W4289933213A5039194215 @default.
• W4289933213 hasAuthorship W4289933213A5050887248 @default.
• W4289933213 hasAuthorship W4289933213A5051853079 @default.
• W4289933213 hasAuthorship W4289933213A5060344910 @default.
• W4289933213 hasAuthorship W4289933213A5065713614 @default.
• W4289933213 hasAuthorship W4289933213A5078634959 @default.
• W4289933213 hasAuthorship W4289933213A5083390606 @default.
• W4289933213 hasAuthorship W4289933213A5089227790 @default.
• W4289933213 hasBestOaLocation W42899332131 @default.
• W4289933213 hasConcept C107130276 @default.
• W4289933213 hasConcept C113162765 @default.
• W4289933213 hasConcept C126322002 @default.
• W4289933213 hasConcept C138816342 @default.
• W4289933213 hasConcept C142724271 @default.
• W4289933213 hasConcept C187212893 @default.
• W4289933213 hasConcept C188816634 @default.
• W4289933213 hasConcept C201903717 @default.
• W4289933213 hasConcept C23131810 @default.
• W4289933213 hasConcept C2776361769 @default.
• W4289933213 hasConcept C2779134260 @default.
• W4289933213 hasConcept C3007834351 @default.
• W4289933213 hasConcept C3008058167 @default.
• W4289933213 hasConcept C524204448 @default.
• W4289933213 hasConcept C62558387 @default.
• W4289933213 hasConcept C71924100 @default.
• W4289933213 hasConcept C72563966 @default.
• W4289933213 hasConceptScore W4289933213C107130276 @default.
• W4289933213 hasConceptScore W4289933213C113162765 @default.
• W4289933213 hasConceptScore W4289933213C126322002 @default.
• W4289933213 hasConceptScore W4289933213C138816342 @default.
• W4289933213 hasConceptScore W4289933213C142724271 @default.
• W4289933213 hasConceptScore W4289933213C187212893 @default.

• next